# Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?

> **NCT03262038** · PHASE4 · TERMINATED · sponsor: **University of Michigan** · enrollment: 46 (actual)

## Conditions studied

- Pruritus
- Nausea/Vomiting

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT03262038
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-07
- **Primary completion:** 2019-08-20
- **Final completion:** 2019-08-20
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** Interim analysis showed no difference between groups
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262038, "Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03262038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*